Feedback / Questions
resecabtagene autoleucel (CABA-201) - Cabaletta Bio
https://www.globenewswire.com/news-release/2025/06/11/3097381/0/en/Cabaletta-Bio-Announces-New-Rese-cel-Safety-and-Efficacy-Data-in-Patients-with-Myositis-Lupus-and-Scleroderma-to-Be-Presented-at-the-EULAR-2025-Congress.html
Jun 11, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next